WeightWatchers is going all-in on trendy new anti-obesity drugs. The gamble might save the company—if it doesn’t kill it first. By Emma Court and Ellen Huet

The CEO Playbook to Navigating Trump
18:56

The Dawn of Music’s AI Era
32:43

The Startup Making Human Embryos With AI-Assisted Robots
37:40